Ischemic preconditioning in humans: models, mediators, and clinical relevance.
about
Postconditioning with isoflurane reduced ischemia-induced brain injury in rats.Pretreatment with volatile anesthetics, but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobutane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemiaPotential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.Isoflurane and coronary heart disease.Preconditioning - endogenous defence mechanisms of the heart.Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning.Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury.Symbolic dynamics to discriminate healthy and ischaemic dilated cardiomyopathy populations: an application to the variability of heart period and QT interval.Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists.Ischemic tolerance.Novel cardioprotective strategy combining three different preconditioning methods to prevent ischemia/reperfusion injury in aged hearts in an improved rabbit model.Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trialChronic sildenafil in men with diabetes and erectile dysfunction.Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease.Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury.Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioningIschemic tolerance as an active and intrinsic neuroprotective mechanism.Molecular aspects of ischaemic postconditioning.Ischemic preconditioning: Interruption of various disorders.Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.Conditioning the Heart: Thirty Years of Research and Still Far from Humans.Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro.Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction.Hypoxic Air Inhalation and Ischemia Interventions Both Elicit Preconditioning Which Attenuate Subsequent Cellular Stress In vivo Following Blood Flow Occlusion and Reperfusion.Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene.Cardiac protection during on-pump coronary artery bypass grafting: ischemic versus isoflurane preconditioning.Warm up phenomenon and preconditioning in clinical practice.Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction.Diazepam versus fentanyl for premedication during percutaneous coronary intervention: results from the Myocardial Protection by Fentanyl during Coronary Intervention (PROFIT) Trial.Myocardium tolerant to an adenosine-dependent ischemic preconditioning stimulus can still be protected by stimuli that employ alternative signaling pathways.Comparison of cardioprotective effects of volatile anesthetics in children undergoing ventricular septal defect closure.Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.Immediate postconditioning during reperfusion attenuates intestinal injury.Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention.NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo.The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.Transcutaneous electrical acupoint stimulation alleviates adverse cardiac remodeling induced by overload training in rats.
P2860
Q30439887-5264821A-31FD-4218-8CF6-57779E315E52Q30441595-B71777D9-950E-4060-85B3-4931CD7CF0A7Q33231214-9DB578FD-CA67-4E44-9C21-7AB6C62043A5Q34092872-1A19A065-DE19-4C17-93E0-81779E61CC47Q34592237-4DAC6C17-3AB1-442D-8510-A3637CE1D96DQ34593774-64A7B6C3-C506-4F28-9409-0365DAB79AEFQ34687823-ED2943E1-9490-4A40-954B-B8C65EB27EC1Q34739977-0A7A4302-5D21-42D9-BEC4-F3D2FC708511Q34802686-A6F11A65-DB97-45D0-AD0E-3553437D2893Q34956769-C6950F38-0F21-4BFE-982C-8CDD4212E105Q35002089-1777F326-C7D3-4432-A797-D992B77BA847Q36081098-44D7AFE3-D739-4B5F-88A5-CC899BDCE08BQ36217903-F54E5CC7-5137-4478-9BA1-FFA859662622Q36651450-E4F49244-08DD-43E5-96E4-7FB4A7878553Q36817657-9A3E1283-8B79-498E-8FC1-62EA53F4D03AQ36835843-40BDE968-5502-43E9-90F3-A886994266B6Q36868364-4AED8731-8AF0-4E1D-AFEC-72FAC2C0B7C4Q36872189-F122C2DB-CAFF-4995-876B-5783BBEEA6D5Q37156312-06BBE68A-1344-40A5-9556-F9146A7051F9Q37268106-CD083E6F-4CBB-4A03-B75D-AE7D08AFC641Q37578683-3663FE1E-75CA-4735-A2A8-7F3DD733E818Q37721389-C221B38A-454A-4243-8151-CA5300588D97Q38350904-96D82D87-218B-4A31-ABCB-8E47B6174DACQ38988516-62C66A5C-B6A9-4C52-9E99-1594456973A7Q39508501-7355BBE1-28FB-4E4F-A84F-879568F2169EQ41188336-DB1DD6A3-ADC8-4249-AC3A-28A15F2DF2F1Q41203178-B79D44C6-EC55-4F2E-A3B4-C2F9A5CE8460Q42513393-9B8DE4A1-3198-4AF6-A7BF-02CA4202E18FQ42959209-D0C9B946-2ED5-4DAA-B2DC-C4DD64B2C4F3Q43017110-CAF38BF3-06A3-407F-830C-C9714F01F4E9Q43737413-CE2742D7-A4E9-4AC7-BCD9-D589A3E1BDF8Q44648472-DD7ABB4C-BC7E-42C1-A678-1CCB2C7011B2Q45107978-E567E3F6-6F99-4C2C-B6EC-4F2EA9DC3304Q45206927-6EAF2638-A5E1-483D-A0B0-2436CD9AFDF8Q45214788-78F09A5F-590C-47E1-BC2F-6F8031B3380DQ46134845-EEC8E7D9-5941-42B1-BAAB-26A20E1293BEQ46194797-E4CF80B4-F539-49E7-BA7C-BFA808D16F59Q46716531-36CABA1C-656B-4A31-841F-F73AC03C8402Q46871340-2F690997-DD97-4756-B2F0-B1C5CCC1AC40Q47446499-A31BFDEA-6BF5-4D44-A587-D05ECE9982F8
P2860
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@ast
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@en
type
label
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@ast
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@en
prefLabel
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@ast
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@en
P2093
P356
P1433
P1476
Ischemic preconditioning in humans: models, mediators, and clinical relevance.
@en
P2093
P304
P356
10.1161/01.CIR.100.5.559
P407
P577
1999-08-01T00:00:00Z